Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 264

1.

Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.

Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenström A; DIGAMI 2 Investigators.

Eur Heart J. 2005 Apr;26(7):650-61. Epub 2005 Feb 23.

PMID:
15728645
2.

[Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication].

Gustafsson I, Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt PR, MacLeod K, Laakso M, Torp-Pedersen CT, Waldenström A; DIGAMI-2 investigatorerne.

Ugeskr Laeger. 2006 Feb 6;168(6):581-4. Danish.

PMID:
16476220
3.

Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.

Ritsinger V, Malmberg K, Mårtensson A, Rydén L, Wedel H, Norhammar A.

Lancet Diabetes Endocrinol. 2014 Aug;2(8):627-33. doi: 10.1016/S2213-8587(14)70088-9. Epub 2014 May 13.

PMID:
24831989
6.

Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial.

Mellbin LG, Malmberg K, Waldenström A, Wedel H, Rydén L; DIGAMI 2 investigators.

Heart. 2009 May;95(9):721-7. doi: 10.1136/hrt.2008.152835. Epub 2008 Nov 24.

PMID:
19029171
7.

The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

Mellbin LG, Malmberg K, Norhammar A, Wedel H, Rydén L; DIGAMI 2 Investigators.

Eur Heart J. 2008 Jan;29(2):166-76. Epub 2007 Dec 21.

PMID:
18156614
9.

Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study.

Mellbin LG, Malmberg K, Norhammar A, Wedel H, Rydén L; DIGAMI 2 Investigators.

Diabetologia. 2011 Jun;54(6):1308-17. doi: 10.1007/s00125-011-2084-x. Epub 2011 Feb 26.

PMID:
21359582
10.
12.

The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial.

Mellbin LG, Malmberg K, Rydén L, Wedel H, Vestberg D, Lind M.

Eur Heart J. 2013 Feb;34(5):374-9. doi: 10.1093/eurheartj/ehs384. Epub 2012 Nov 9.

PMID:
23144046
13.
14.

Effect of gender on prognosis in patients with myocardial infarction and type 2 diabetes.

Venskutonyte L, Malmberg K, Norhammar A, Wedel H, Rydén L.

J Intern Med. 2010 Jul;268(1):75-82. doi: 10.1111/j.1365-2796.2010.02215.x. Epub 2010 Jan 20.

15.

Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study.

Malmberg K, Rydén L, Hamsten A, Herlitz J, Waldenström A, Wedel H.

Cardiovasc Res. 1997 Apr;34(1):248-53. Erratum in: Cariovasc Res 1997 Dec;36(3):460.

PMID:
9217897
17.

Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).

Meier JJ, Deifuss S, Klamann A, Schmiegel W, Nauck MA; LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).

Exp Clin Endocrinol Diabetes. 2003 Sep;111(6):344-50.

PMID:
14520601
20.

Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study.

Almbrand B, Johannesson M, Sjöstrand B, Malmberg K, Rydén L.

Eur Heart J. 2000 May;21(9):733-9.

PMID:
10739728

Supplemental Content

Support Center